← ANALYST RATINGS · TIPRANKS
Labcorp Holdings (LH): analyst forecast and price target
Analyst consensus
Strong Buy10 Buy3 Hold0 Sell
Ratings of 13 analysts in the last 3 months12-month forecast
Based on 13 price targets given in the last 3 months, the average target is $344, the highest $380, the lowest $306. The average is +8.0% from the last price of $318.
Analyst ratings 17
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Lu Li★★★★★★★★★★#5185 · hits 80% · avg +11.8% | UBS | $360 | Buy | +13.2% | Reiterated | 15.10.26on TipRanks Oct 16 04:55 | +2.2%next day −1.1% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $330 | Hold | +3.8% | Reiterated | 07.10.26on TipRanks 04:00 | +0.3%next day +1.1% · 5 days +2.7% | ↗ |
| Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% | Leerink Partners | — | Buy | — | Reiterated | 23.09.26on TipRanks Sep 25 05:00 | −1.7%next day +1.7% · 5 days +2.0% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $356 | Buy | +12.0% | Reiterated | 23.09.26on TipRanks Sep 22 21:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $355 → $358+0.8% | Buy | +12.6% | Reiterated | 23.09.26on TipRanks Sep 22 21:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $352 → $351−0.3% | Hold | +10.4% | Reiterated | 23.09.26on TipRanks Sep 22 21:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $344 → $337−2.0% | Hold | +6.0% | Reiterated | 23.09.26on TipRanks Sep 22 21:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $366 → $363−0.8% | Buy | +14.2% | Reiterated | 23.09.26on TipRanks Sep 22 21:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $363 | Buy | +14.2% | Reiterated | 23.09.26on TipRanks Sep 22 21:05 | — | |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | $350 → $365+4.3% | Buy | +14.8% | Reiterated | 21.09.26on TipRanks 07:25 | −1.5%next day −2.9% · 5 days −2.5% | ↗ |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $340 | Buy | +6.9% | Reiterated | 11.09.26on TipRanks 09:45 | +0.6%next day +1.7% · 5 days +3.0% | ↗ |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $361 → $380+5.3% | Buy | +19.5% | Reiterated | 11.09.26on TipRanks 08:10 | +0.6%next day +1.7% · 5 days +3.0% | ↗ |
| Jared Haase★★★★★★★★★★#1700 · hits 89% · avg +24.8% | William Blair | — | Buy | — | Reiterated | 11.09.26on TipRanks 07:35 | +0.6%next day +1.7% · 5 days +3.0% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $320 → $330+3.1% | Hold | +3.8% | Reiterated | 11.09.26on TipRanks 05:15 | +0.6%next day +1.7% · 5 days +3.0% | ↗ |
| Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% | J.P. Morgan | — | Buy | — | Reiterated | 26.08.26on TipRanks 10:15 | −0.6%next day −0.4% · 5 days −0.9% | ↗ |
| Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% | Mizuho Securities | $320 → $355+10.9% | Buy | +11.7% | Reiterated | 10.08.26on TipRanks 07:25 | +0.7%next day +0.7% · 5 days +0.7% | ↗ |
| David Westenberg★★★★★★★★★★#602 · hits 56% · avg +17.3% | Piper Sandler | $300 → $309+3.0% | Hold | −2.8% | Reiterated | 04.08.26on TipRanks 07:45 | −0.2%next day +0.7% · 5 days +3.3% | ↗ |
| Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% | Deutsche Bank | $276 → $306+10.9% | Hold | −3.8% | Assigned | 31.07.26on TipRanks 09:00 | −2.7%next day −2.0% · 5 days −0.3% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $308 → $338+9.7% | Buy | +6.3% | Reiterated | 31.07.26on TipRanks 08:18 | −2.7%next day −2.0% · 5 days −0.3% | ↗ |
| Eric Coldwell★★★★★★★★★★#1091 · hits 59% · avg +7.7% | Robert W. Baird | $338 → $352+4.1% | Buy | +10.7% | Reiterated | 31.07.26on TipRanks 07:35 | −2.7%next day −2.0% · 5 days −0.3% | ↗ |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $320 → $360+12.5% | Buy | +13.2% | Reiterated | 30.07.26on TipRanks Jul 31 05:42 | +1.1%next day −2.7% · 5 days −3.3% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | $310 | Buy | −2.5% | Reiterated | 02.06.26on TipRanks 10:35 | +0.2%next day +1.2% · 5 days +8.2% | ↗ |
| Patrick B Donnelly★★★★★★★★★★#2106 · hits 54% · avg +6.0% | Citi | $325 | Buy | +2.2% | Reiterated | 02.01.26on TipRanks Jan 5 07:30 | +0.1%next day −0.1% · 5 days −1.5% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Labcorp Holdings
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $344 at a price of $308 (+11.5%); now: $344 at $318 (+8.0%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 7 | 8 | 12 | 11 | 17 | 11 |
| Hold | 2 | 2 | 3 | 3 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 28.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $4.65 (from $4.49 to $4.73). Last quarter: $4.99.
Sales
Next quarter’s sales estimate — $3.8B (from $3.7B to $3.8B). Last quarter: $3.7B.
Best top-analyst consensus in the sector · Healthcare
About Labcorp Holdings
- CEO: Adam H. Schechter
- Employees: 71,000
- 358 South Main Street, Burlington, NC, 27215, US
- www.labcorp.com
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Data from the stock’s TipRanks forecast page, read 11 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗